Literature DB >> 30497675

Cutaneous Melanoma-A Review in Detection, Staging, and Management.

Rebecca I Hartman1, Jennifer Y Lin2.   

Abstract

Melanoma is an increasingly common cancer in the United States, although mortality has likely stabilized. Diagnosis relies on a skilled practitioner with the aid of dermoscopy and initial local surgical management is a mainstay of treatment. Recent changes in staging emphasize continued use of sentinel lymph node biopsy to aid in prognostication although routine complete lymph node dissection has fallen out of favor. Advances in systemic treatment options, including targeted and immunotherapy, have dramatically changed the treatment paradigm for advanced melanoma and improved outcome. Prevention via sun protection remains a critical tool in efforts to limit the burden of this disease.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cutaneous melanoma; Immunotherapy; Malignant melanoma; Melanoma; Sentinel lymph node biopsy; Targeted therapy

Mesh:

Year:  2019        PMID: 30497675     DOI: 10.1016/j.hoc.2018.09.005

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  18 in total

Review 1.  The Treatment of Advanced Melanoma: Therapeutic Update.

Authors:  Alessia Villani; Luca Potestio; Gabriella Fabbrocini; Giancarlo Troncone; Umberto Malapelle; Massimiliano Scalvenzi
Journal:  Int J Mol Sci       Date:  2022-06-07       Impact factor: 6.208

2.  Neglected cutaneous skin malignancy: A patient with concurrent giant basal cell carcinoma and melanoma.

Authors:  L Sun; E Tan
Journal:  Skin Health Dis       Date:  2021-10-05

3.  PGC-1α induced mitochondrial biogenesis in stromal cells underpins mitochondrial transfer to melanoma.

Authors:  Prakrit R Kumar; Mona Saad; Charlotte Hellmich; Jayna J Mistry; Jamie A Moore; Shannon Conway; Christopher J Morris; Kristian M Bowles; Marc D Moncrieff; Stuart A Rushworth
Journal:  Br J Cancer       Date:  2022-03-26       Impact factor: 9.075

Review 4.  RAGE Signaling in Melanoma Tumors.

Authors:  Olamide T Olaoba; Sultan Kadasah; Stefan W Vetter; Estelle Leclerc
Journal:  Int J Mol Sci       Date:  2020-11-26       Impact factor: 5.923

5.  A Four-Gene-Based Prognostic Model Predicts Overall Survival in Patients With Cutaneous Melanoma.

Authors:  Xiaoxia Tong; Xiaofei Qu; Mengyun Wang
Journal:  Front Oncol       Date:  2021-03-24       Impact factor: 6.244

6.  Potential effect of EGCG on the anti-tumor efficacy of metformin in melanoma cells.

Authors:  An'an Xu; Jeehyun Lee; Yueling Zhao; Yuefei Wang; Xiaoli Li; Ping Xu
Journal:  J Zhejiang Univ Sci B       Date:  2021-07-15       Impact factor: 3.066

7.  Living Bacteria-Based Immuno-Photodynamic Therapy: Metabolic Labeling of Clostridium butyricum for Eradicating Malignant Melanoma.

Authors:  Leilei Shi; Xiaoxiao Liu; Yuzhen Li; Sha Li; Wenbo Wu; Xihui Gao; Bin Liu
Journal:  Adv Sci (Weinh)       Date:  2022-03-11       Impact factor: 17.521

8.  Metastatic Melanoma Patient-Derived Xenografts Respond to MDM2 Inhibition as a Single Agent or in Combination with BRAF/MEK Inhibition.

Authors:  Rebecca L Shattuck-Brandt; Sheau-Chiann Chen; Emily Murray; Christopher Andrew Johnson; Holly Crandall; Jamye F O'Neal; Rami Nayef Al-Rohil; Caroline A Nebhan; Vijaya Bharti; Kimberly B Dahlman; Gregory D Ayers; Chi Yan; Mark C Kelley; Rondi M Kauffmann; Mary Hooks; Ana Grau; Douglas B Johnson; Anna E Vilgelm; Ann Richmond
Journal:  Clin Cancer Res       Date:  2020-03-31       Impact factor: 13.801

Review 9.  Melanoma-Bearing Libechov Minipig (MeLiM): The Unique Swine Model of Hereditary Metastatic Melanoma.

Authors:  Vratislav Horak; Anna Palanova; Jana Cizkova; Veronika Miltrova; Petr Vodicka; Helena Kupcova Skalnikova
Journal:  Genes (Basel)       Date:  2019-11-09       Impact factor: 4.096

10.  Second Primary Cancers in Melanoma Patients Critically Shorten Survival.

Authors:  Guoqiao Zheng; Subhayan Chattopadhyay; Kristina Sundquist; Jan Sundquist; Asta Försti; Akseli Hemminki; Kari Hemminki
Journal:  Clin Epidemiol       Date:  2020-01-23       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.